VAERS reports by lot

Moderna COVID-19 lot 003J212A: VAERS reports

29 VAERS reports list lot 003J212A as a Moderna COVID-19 vaccine, received between 2022-01-11 and 2023-12-15. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
21%
Marked serious
2
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2218%
Respiratory2016%
Cardiac / Cardiovascular1915%
Dermatological (non-injection-site)1512%
Neurological1210%
Gastrointestinal1210%
Injection-site / Local reaction119%
Allergic / Anaphylactic65%
Musculoskeletal54%
Psychiatric / Neuropsychiatric32%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan4
California2
Illinois2
Texas2
New York2
Ohio2
Florida2
North Dakota1
Tennessee1
Pennsylvania1
Oklahoma1
Iowa1

Reports by month received

2022-017
2022-026
2022-032
2022-041
2022-053
2022-063
2022-073
2022-121
2023-011
2023-041
2023-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.